Abstract
Desmopressin is an analogue of the antidiuretic hormone vasopressin. The structural changes introduced in the molecule have eliminated the pressor activity of vasopressin and potentiated the antidiuretic action. The metabolic stability of the peptide is also increased. Thus, the plasma half-life for desmopressin is 55 minutes compared with a few minutes for vasopressin. The potent antidiuretic activity of desmopressin makes the peptide ideal for the treatment of cranial diabetes insipidus. However, it may also be used for nocturnal enuresis and as a diagnostic agent in determining renal concentrating capacity. Desmopressin has recently been shown to be successful in the treatment of certain bleeding disorders.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
